Sunitix 50 Mg (Sunitinib) – 6 Capsules

Sunitix 50 Mg (Sunitinib), developed by Beacon Pharmaceuticals Ltd. and distributed by Unit Pharmacy, stands as a significant advancement in the field of oncology. Containing Sunitinib, a multi-targeted receptor tyrosine kinase (RTK) inhibitor, this medication offers a potent solution for tackling various types of cancers, notably renal cell carcinoma (RCC), gastrointestinal stromal tumors (GISTs), and pancreatic neuroendocrine tumors (pNETs).

Sunitix 50 mg is primarily indicated for:

• Renal Cell Carcinoma (RCC): It is a first-line treatment option for patients with advanced RCC, offering a new approach to managing this kidney cancer.
• Gastrointestinal Stromal Tumors (GISTs): Sunitix is also effective in treating GISTs, especially in cases where the disease is unresponsive to standard treatments like imatinib.
• Pancreatic Neuroendocrine Tumors (pNETs): Additionally, Sunitix is used in the treatment of advanced pNETs, providing an option for patients who have few alternatives.

Product Feature:

You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Sunitix 50 Mg (Sunitinib) medicine.